Rhythm Diagnostic Systems
RDS is dedicated to advancing patient pathways through innovative remote patient monitoring solutions. Combining biosensor technologies with predictive medicine, RDS aims to improve healthcare quality, efficiency, and sustainability. Headquartered in Strasbourg, France, RDS is part of the Future4Care accelerator and has received multiple awards and patents for its innovative solutions.
Industries
Nr. of Employees
small (1-50)
Rhythm Diagnostic Systems
Products
Wearable multi-parameter remote patient monitoring system (Class IIa medical device)
A medical monitoring solution combining a wearable adhesive monitor that captures multiple physiological parameters continuously and a cloud platform that transforms these data into clinical insights. Intended for non-critical settings in hospital and home; reported clinical validation through six investigations and CE marked as Class IIa device.
Wearable multi-parameter remote patient monitoring system (Class IIa medical device)
A medical monitoring solution combining a wearable adhesive monitor that captures multiple physiological parameters continuously and a cloud platform that transforms these data into clinical insights. Intended for non-critical settings in hospital and home; reported clinical validation through six investigations and CE marked as Class IIa device.
Services
Turnkey and customizable services to deploy wearable remote monitoring solutions and integrate them with clinical workflows.
Turnkey and customizable services to deploy wearable remote monitoring solutions and integrate them with clinical workflows.
Expertise Areas
- Remote patient monitoring
- Clinical validation and clinical investigations
- Wearable biosensor development
- Cloud-based clinical data analytics and trend analysis
Key Technologies
- Wearable adhesive biosensors
- Multi-parameter vital sign monitoring
- High-frequency physiological data acquisition
- On-device/edge signal processing
News & Updates
October 25, 2024: RDS joins the exclusive EIC Scaling Club.
October 16, 2024: RDS was selected for the France 2030 Export Program.
September 15, 2024: Deployment of MultiSense® telemonitoring at Hôpital Universitaire de Bruxelles.
RDS received the i-Lab prize in 2020.
RDS was awarded the Grand Prix de l’Académie des Technologies in 2022.
RDS received the i-Nov award in 2023.
October 25, 2024: RDS joins the exclusive EIC Scaling Club.
October 16, 2024: RDS was selected for the France 2030 Export Program.
September 15, 2024: Deployment of MultiSense® telemonitoring at Hôpital Universitaire de Bruxelles.
RDS received the i-Lab prize in 2020.
RDS was awarded the Grand Prix de l’Académie des Technologies in 2022.
RDS received the i-Nov award in 2023.